Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeannette Lee

Concepts (475)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
19
2023
394
3.070
 Why?
Anus Neoplasms
10
2023
33
2.310
 Why?
Acquired Immunodeficiency Syndrome
11
2022
66
1.740
 Why?
Prostatic Hyperplasia
10
2015
44
1.580
 Why?
Parkinson Disease
2
2023
180
1.350
 Why?
Randomized Controlled Trials as Topic
8
2024
596
1.320
 Why?
Chlamydia Infections
8
2017
119
1.260
 Why?
Papillomavirus Infections
5
2022
163
1.120
 Why?
Chlamydia trachomatis
6
2017
42
1.100
 Why?
Sarcoma, Kaposi
11
2022
72
1.090
 Why?
Lymphoma, AIDS-Related
10
2020
24
1.070
 Why?
Stroke
5
2023
526
1.070
 Why?
Brain Ischemia
2
2023
169
0.970
 Why?
Plant Extracts
5
2013
193
0.970
 Why?
Serenoa
5
2013
7
0.940
 Why?
Brain
7
2023
1387
0.900
 Why?
Phytotherapy
3
2012
38
0.870
 Why?
Umbilical Cord
2
2020
33
0.850
 Why?
Rural Population
4
2023
600
0.850
 Why?
Humans
96
2024
54284
0.840
 Why?
Lymphoma, Non-Hodgkin
6
2021
63
0.780
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1056
0.760
 Why?
Middle Aged
49
2021
13088
0.750
 Why?
Research Design
5
2022
374
0.740
 Why?
Fetal Blood
2
2019
67
0.720
 Why?
Adult
47
2022
14207
0.660
 Why?
Inflammation
3
2021
674
0.660
 Why?
Patient Participation
1
2018
70
0.630
 Why?
Vaginosis, Bacterial
2
2015
14
0.600
 Why?
Male
57
2022
27334
0.600
 Why?
Mammography
1
2016
95
0.560
 Why?
Decision Making
1
2018
290
0.550
 Why?
Neoplasms
3
2023
1316
0.540
 Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
55
0.520
 Why?
Aged
28
2020
10054
0.510
 Why?
Population Density
1
2014
21
0.510
 Why?
Pelvic Inflammatory Disease
2
2018
11
0.500
 Why?
AIDS-Related Opportunistic Infections
5
2016
41
0.500
 Why?
Rats
7
2023
3415
0.500
 Why?
Female
45
2022
28441
0.490
 Why?
Carcinoma in Situ
3
2013
74
0.490
 Why?
Antineoplastic Agents
8
2023
1300
0.480
 Why?
Uterine Cervicitis
1
2013
4
0.460
 Why?
Cytokines
5
2023
676
0.460
 Why?
Anti-Bacterial Agents
5
2020
820
0.450
 Why?
Hydrocephalus, Normal Pressure
1
2012
1
0.450
 Why?
Urethritis
2
2012
9
0.450
 Why?
Infarction, Middle Cerebral Artery
3
2023
44
0.440
 Why?
Finasteride
4
2015
9
0.440
 Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
106
0.430
 Why?
Research Subjects
1
2013
58
0.430
 Why?
Guideline Adherence
1
2013
148
0.430
 Why?
Subarachnoid Hemorrhage
1
2012
65
0.420
 Why?
Patient Dropouts
1
2012
60
0.410
 Why?
Breast Neoplasms
3
2017
1248
0.410
 Why?
Carcinoma, Non-Small-Cell Lung
1
2013
164
0.410
 Why?
Urologic Diseases
1
2011
11
0.400
 Why?
HIV-1
6
2020
72
0.390
 Why?
Lung Neoplasms
2
2013
642
0.380
 Why?
Stem Cell Transplantation
2
2023
196
0.370
 Why?
Animals
15
2023
14385
0.370
 Why?
United States
10
2023
5217
0.350
 Why?
Lymphedema
2
2022
43
0.350
 Why?
Asthma
2
2024
293
0.350
 Why?
HIV Seropositivity
3
2021
28
0.350
 Why?
Patient Selection
1
2011
286
0.350
 Why?
Lower Urinary Tract Symptoms
3
2013
6
0.350
 Why?
Young Adult
16
2018
4318
0.350
 Why?
Quality of Life
6
2024
922
0.340
 Why?
Intestinal Mucosa
2
2021
259
0.330
 Why?
Gonorrhea
2
2020
15
0.320
 Why?
Polymorphism, Single Nucleotide
3
2017
552
0.320
 Why?
Superior Colliculi
1
2007
7
0.320
 Why?
Azithromycin
4
2020
42
0.310
 Why?
Stem Cells
2
2019
193
0.310
 Why?
Dogs
1
2007
217
0.310
 Why?
Th1 Cells
2
2017
50
0.300
 Why?
Risk Factors
8
2022
3935
0.290
 Why?
Rats, Sprague-Dawley
6
2021
1663
0.290
 Why?
Vascular Endothelial Growth Factor A
4
2017
230
0.280
 Why?
Mycoplasma genitalium
2
2018
4
0.280
 Why?
Doxazosin
3
2015
3
0.280
 Why?
Mycoplasma Infections
2
2018
9
0.270
 Why?
Cyclophosphamide
9
2021
172
0.270
 Why?
Treatment Outcome
17
2020
5604
0.270
 Why?
Doxycycline
3
2015
46
0.270
 Why?
Anti-Infective Agents
2
2020
110
0.270
 Why?
Prospective Studies
11
2022
2604
0.260
 Why?
Multicenter Studies as Topic
4
2024
91
0.260
 Why?
Cancer Vaccines
1
2006
103
0.260
 Why?
Vincristine
8
2021
98
0.260
 Why?
Hematopoietic Stem Cell Transplantation
3
2018
573
0.250
 Why?
Air Filters
1
2024
1
0.250
 Why?
Thymus Gland
2
2021
45
0.240
 Why?
Adolescent
13
2022
6897
0.240
 Why?
Air Pollution, Indoor
1
2024
28
0.240
 Why?
Double-Blind Method
4
2013
742
0.240
 Why?
Bronchiolitis
1
2024
29
0.240
 Why?
5-alpha Reductase Inhibitors
2
2015
6
0.240
 Why?
Prevalence
6
2021
1025
0.240
 Why?
Homosexuality, Male
3
2022
56
0.240
 Why?
Hyperbaric Oxygenation
1
2023
17
0.240
 Why?
Neurons
1
2007
486
0.240
 Why?
Substantia Nigra
1
2023
16
0.230
 Why?
alpha-Synuclein
1
2023
13
0.230
 Why?
Doxorubicin
8
2021
259
0.230
 Why?
Transplantation Conditioning
2
2018
86
0.230
 Why?
CD4 Lymphocyte Count
6
2020
35
0.230
 Why?
Herpesvirus 8, Human
5
2020
90
0.230
 Why?
Informatics
1
2023
9
0.230
 Why?
Prednisone
7
2021
111
0.220
 Why?
Neonatal Abstinence Syndrome
1
2023
25
0.220
 Why?
Tumor Necrosis Factor-alpha
2
2017
434
0.220
 Why?
Feasibility Studies
2
2021
398
0.220
 Why?
Brachytherapy
1
2022
42
0.220
 Why?
Cross-Sectional Studies
3
2021
1693
0.220
 Why?
Watchful Waiting
1
2022
29
0.220
 Why?
Follow-Up Studies
8
2019
2387
0.210
 Why?
Medical Records
1
2022
92
0.210
 Why?
Absorptiometry, Photon
1
2003
174
0.210
 Why?
Child
8
2024
7341
0.210
 Why?
Substance Withdrawal Syndrome
1
2023
179
0.210
 Why?
Viral Load
6
2020
85
0.210
 Why?
Genome-Wide Association Study
3
2018
190
0.210
 Why?
Vitamin D Deficiency
1
2022
53
0.210
 Why?
Brain Injuries
1
2023
183
0.200
 Why?
Mouth Diseases
1
2021
6
0.200
 Why?
Precancerous Conditions
1
2022
93
0.200
 Why?
Vaccination
3
2022
294
0.200
 Why?
Vaccines
1
2022
65
0.200
 Why?
Case-Control Studies
3
2014
1228
0.200
 Why?
Lymphocyte Activation
3
2017
197
0.200
 Why?
Papillomaviridae
2
2016
107
0.200
 Why?
Clinical Trials as Topic
5
2020
490
0.200
 Why?
Pluripotent Stem Cells
1
2021
9
0.200
 Why?
T-Lymphocyte Subsets
2
2017
41
0.200
 Why?
Physical Conditioning, Animal
1
2021
58
0.200
 Why?
Mass Screening
2
2015
370
0.200
 Why?
Neoplasm Staging
4
2022
806
0.200
 Why?
Primary Health Care
2
2022
401
0.190
 Why?
Papillomavirus Vaccines
2
2013
68
0.190
 Why?
Analgesics, Opioid
2
2023
501
0.190
 Why?
Drug Therapy, Combination
5
2015
426
0.190
 Why?
Vagina
2
2018
47
0.190
 Why?
Disease Models, Animal
4
2019
1639
0.190
 Why?
Etoposide
5
2021
85
0.190
 Why?
Cross-Over Studies
1
2021
250
0.190
 Why?
Anti-HIV Agents
3
2020
43
0.190
 Why?
Transplantation, Autologous
3
2018
476
0.190
 Why?
Spleen
1
2021
186
0.190
 Why?
Genes, myc
1
2020
47
0.190
 Why?
Gene Frequency
2
2017
120
0.190
 Why?
Enzyme Inhibitors
2
2016
446
0.180
 Why?
Overweight
1
2022
240
0.180
 Why?
Uterine Cervical Neoplasms
1
2022
276
0.180
 Why?
Cell Differentiation
2
2021
720
0.180
 Why?
Dihydroxyphenylalanine
1
2019
6
0.180
 Why?
Aged, 80 and over
5
2013
3431
0.180
 Why?
Dopaminergic Neurons
1
2019
23
0.170
 Why?
Empathy
1
2019
50
0.170
 Why?
Ablation Techniques
1
2019
25
0.170
 Why?
Altruism
1
2018
14
0.170
 Why?
Social Environment
1
2019
96
0.170
 Why?
Central Nervous System Diseases
1
2019
30
0.170
 Why?
Sodium, Dietary
1
2019
27
0.170
 Why?
Asymptomatic Infections
1
2018
6
0.170
 Why?
Antiviral Agents
2
2013
188
0.160
 Why?
Acoustic Stimulation
1
2018
99
0.160
 Why?
Dopamine
1
2019
190
0.160
 Why?
Sexually Transmitted Diseases
1
2018
49
0.160
 Why?
Enzyme-Linked Immunosorbent Assay
3
2017
314
0.160
 Why?
Mitochondria
2
2020
489
0.160
 Why?
Energy Metabolism
1
2020
311
0.160
 Why?
Protein Kinase Inhibitors
2
2023
216
0.160
 Why?
Hyperthermia, Induced
1
2019
107
0.160
 Why?
Mucous Membrane
1
2017
33
0.160
 Why?
Chlamydia
1
2017
25
0.150
 Why?
Blood Cells
1
2017
58
0.150
 Why?
DNA, Circular
1
2017
22
0.150
 Why?
Antibodies, Bacterial
1
2017
38
0.150
 Why?
Clostridium Infections
1
2018
62
0.150
 Why?
Pilot Projects
3
2019
808
0.150
 Why?
Genetic Predisposition to Disease
2
2018
570
0.150
 Why?
Biopsy
2
2022
692
0.150
 Why?
Clonal Evolution
1
2017
60
0.150
 Why?
Immunoglobulins
1
2017
89
0.150
 Why?
Immunoglobulin G
1
2017
226
0.140
 Why?
Anus Diseases
1
2016
5
0.140
 Why?
Telemedicine
1
2022
449
0.140
 Why?
Sentinel Lymph Node Biopsy
1
2017
127
0.140
 Why?
Mannitol
1
2016
15
0.140
 Why?
Lymph Node Excision
1
2017
140
0.140
 Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
8
0.140
 Why?
Thiazoles
1
2016
61
0.140
 Why?
Diagnostic Self Evaluation
1
2015
15
0.140
 Why?
Guidelines as Topic
1
2016
125
0.140
 Why?
Blood-Brain Barrier
1
2016
59
0.140
 Why?
Comorbidity
2
2018
663
0.140
 Why?
Anal Canal
3
2023
23
0.140
 Why?
Tinidazole
2
2012
5
0.130
 Why?
CD4-Positive T-Lymphocytes
1
2017
180
0.130
 Why?
Educational Status
1
2016
260
0.130
 Why?
Burkitt Lymphoma
1
2015
29
0.130
 Why?
T-Lymphocytes
1
2017
373
0.130
 Why?
Dose-Response Relationship, Drug
4
2013
1476
0.130
 Why?
Imidazoles
1
2016
142
0.130
 Why?
Drug Administration Schedule
5
2020
401
0.130
 Why?
Menarche
1
2014
8
0.130
 Why?
Lymph Nodes
1
2017
284
0.130
 Why?
Stomatitis
1
2014
18
0.130
 Why?
Chromosomes, Human, Pair 2
1
2014
29
0.130
 Why?
Immunophenotyping
2
2017
117
0.130
 Why?
Data Collection
3
2023
321
0.120
 Why?
Disease-Free Survival
5
2016
485
0.120
 Why?
Obesity
3
2022
1202
0.120
 Why?
Hypogonadism
1
2013
5
0.120
 Why?
Benzamides
1
2013
54
0.120
 Why?
SEER Program
1
2013
91
0.120
 Why?
Stress Disorders, Post-Traumatic
1
2018
394
0.120
 Why?
Urban Population
1
2014
182
0.120
 Why?
Incidence
4
2018
1082
0.120
 Why?
Organophosphonates
1
2013
5
0.110
 Why?
Health Surveys
1
2014
263
0.110
 Why?
Perineum
1
2013
24
0.110
 Why?
Testosterone
1
2013
119
0.110
 Why?
Carcinoma, Squamous Cell
1
2016
384
0.110
 Why?
Placebos
1
2013
90
0.110
 Why?
Adrenergic alpha-Antagonists
2
2009
24
0.110
 Why?
Cytosine
1
2013
29
0.110
 Why?
DNA, Viral
3
2020
142
0.110
 Why?
Heart Failure
1
2019
541
0.110
 Why?
tau Proteins
1
2012
30
0.110
 Why?
Piperazines
1
2013
116
0.110
 Why?
Stress, Psychological
2
2019
270
0.110
 Why?
Prostate
2
2015
117
0.110
 Why?
HIV
3
2023
26
0.110
 Why?
Trichomonas Infections
1
2012
4
0.110
 Why?
Trichomonas vaginalis
1
2012
5
0.110
 Why?
Transforming Growth Factor beta1
1
2012
66
0.110
 Why?
Vulvar Neoplasms
1
2013
54
0.110
 Why?
Pyrimidines
1
2013
196
0.110
 Why?
Medicare
1
2013
241
0.100
 Why?
Urination Disorders
1
2011
19
0.100
 Why?
Androgen Antagonists
1
2011
15
0.100
 Why?
Sirolimus
1
2012
65
0.100
 Why?
CD8-Positive T-Lymphocytes
2
2017
116
0.100
 Why?
Kenya
2
2022
13
0.100
 Why?
Time Factors
5
2023
3213
0.100
 Why?
Antibiotics, Antineoplastic
1
2012
85
0.100
 Why?
Quinazolinones
1
2011
7
0.100
 Why?
Immunohistochemistry
5
2017
1089
0.100
 Why?
Human papillomavirus 16
2
2013
48
0.100
 Why?
Infant, Newborn
3
2023
2907
0.100
 Why?
Microscopy, Confocal
2
2007
110
0.090
 Why?
Arkansas
1
2016
2100
0.090
 Why?
Social Class
1
2011
110
0.090
 Why?
Practice Guidelines as Topic
1
2013
492
0.090
 Why?
Methotrexate
2
2015
73
0.090
 Why?
Piperidines
1
2011
103
0.090
 Why?
Plant Bark
1
2009
6
0.090
 Why?
Multivariate Analysis
1
2012
643
0.090
 Why?
Prognosis
5
2017
2118
0.090
 Why?
Chronic Disease
1
2012
614
0.090
 Why?
Colorectal Neoplasms
1
2013
236
0.090
 Why?
Valproic Acid
1
2009
32
0.090
 Why?
Ki-67 Antigen
1
2009
63
0.090
 Why?
Multiple Myeloma
2
2014
3035
0.090
 Why?
Socioeconomic Factors
1
2012
642
0.090
 Why?
India
2
2021
79
0.090
 Why?
Tetracyclines
2
2006
7
0.080
 Why?
Logistic Models
1
2012
995
0.080
 Why?
Fruit
1
2009
143
0.080
 Why?
Neoplasm Recurrence, Local
1
2012
644
0.080
 Why?
Fluorescent Antibody Technique, Indirect
1
2007
26
0.080
 Why?
Antiretroviral Therapy, Highly Active
3
2015
40
0.080
 Why?
Glomerulonephritis, IGA
1
2007
13
0.080
 Why?
Galactose
1
2007
29
0.080
 Why?
Eye Enucleation
1
2007
13
0.080
 Why?
Amacrine Cells
1
2007
1
0.080
 Why?
Immunoglobulin A
1
2007
54
0.080
 Why?
Chiroptera
1
2007
6
0.080
 Why?
Parvalbumins
1
2007
16
0.080
 Why?
Survival Analysis
3
2017
735
0.080
 Why?
Adaptive Immunity
2
2017
39
0.080
 Why?
Cisplatin
2
2022
352
0.080
 Why?
Glioblastoma
1
2009
99
0.080
 Why?
Sexual Partners
2
2018
38
0.070
 Why?
gamma-Aminobutyric Acid
1
2007
76
0.070
 Why?
Antibodies
1
2007
178
0.070
 Why?
Retina
1
2007
64
0.070
 Why?
Receptors, AMPA
1
2006
17
0.070
 Why?
Cell Polarity
1
2006
19
0.070
 Why?
Disease Progression
4
2013
913
0.070
 Why?
Retinal Ganglion Cells
1
2006
23
0.070
 Why?
Chaperonins
1
2006
3
0.070
 Why?
Chaperonin 60
1
2006
5
0.070
 Why?
Dose-Response Relationship, Immunologic
1
2006
16
0.070
 Why?
Lymphocyte Count
1
2006
23
0.070
 Why?
Papillomavirus E7 Proteins
1
2006
33
0.070
 Why?
Regression Analysis
2
2018
445
0.070
 Why?
Viral Vaccines
1
2006
14
0.070
 Why?
HIV Protease Inhibitors
1
2006
3
0.070
 Why?
Sexual Behavior
2
2018
126
0.070
 Why?
Synapses
1
2006
90
0.070
 Why?
Interferon-alpha
1
2006
50
0.070
 Why?
Nephrosis, Lipoid
1
2005
7
0.070
 Why?
Arterioles
1
2005
35
0.070
 Why?
Recombinant Fusion Proteins
1
2006
206
0.070
 Why?
Body Mass Index
2
2022
713
0.070
 Why?
Brain Neoplasms
1
2009
284
0.070
 Why?
Matrix Metalloproteinase 9
3
2017
93
0.070
 Why?
Severity of Illness Index
2
2023
1084
0.060
 Why?
Aminoimidazole Carboxamide
1
2004
3
0.060
 Why?
Leucovorin
1
2004
18
0.060
 Why?
Phenotype
2
2017
820
0.060
 Why?
Purines
1
2004
45
0.060
 Why?
Dust
1
2024
25
0.060
 Why?
Neutropenia
2
2020
120
0.060
 Why?
Confidence Intervals
2
2015
167
0.060
 Why?
Genotype
2
2017
599
0.060
 Why?
Particulate Matter
1
2024
56
0.060
 Why?
Carbon
1
2024
61
0.060
 Why?
Folic Acid
1
2004
139
0.060
 Why?
Arthritis, Rheumatoid
1
2004
130
0.060
 Why?
Cytochrome P-450 CYP3A
1
2023
82
0.060
 Why?
Femur Neck
1
2003
8
0.060
 Why?
Africa South of the Sahara
1
2022
4
0.060
 Why?
Hip
1
2003
26
0.060
 Why?
Quality Control
1
2003
101
0.060
 Why?
Narcotics
1
2023
107
0.050
 Why?
Sample Size
1
2022
48
0.050
 Why?
Eating
1
2023
155
0.050
 Why?
Administration, Oral
3
2013
459
0.050
 Why?
Vitamins
1
2022
72
0.050
 Why?
Matrix Metalloproteinase Inhibitors
1
2002
12
0.050
 Why?
Femur
1
2003
144
0.050
 Why?
Tetracycline
1
2002
21
0.050
 Why?
Bacterial Proteins
1
2006
454
0.050
 Why?
Radiotherapy Dosage
1
2022
243
0.050
 Why?
Spine
1
2003
111
0.050
 Why?
Vitamin D
1
2022
101
0.050
 Why?
Sleep
1
2023
188
0.050
 Why?
Fibroblast Growth Factor 2
2
2017
33
0.050
 Why?
Leg
1
2022
130
0.050
 Why?
Museums
1
2021
3
0.050
 Why?
Regenerative Medicine
1
2021
9
0.050
 Why?
Alprostadil
1
2021
12
0.050
 Why?
Zimbabwe
1
2020
2
0.050
 Why?
Malawi
1
2020
11
0.050
 Why?
Wharton Jelly
1
2020
1
0.050
 Why?
Uganda
1
2020
33
0.050
 Why?
Herpesvirus 4, Human
1
2020
38
0.050
 Why?
Cell Shape
1
2020
23
0.050
 Why?
Oxygen
1
2023
361
0.050
 Why?
Neisseria gonorrhoeae
1
2020
8
0.050
 Why?
Herpesviridae Infections
1
2020
46
0.050
 Why?
Antibodies, Monoclonal
1
2005
562
0.050
 Why?
Body Composition
1
2003
349
0.050
 Why?
Ceftriaxone
1
2020
29
0.050
 Why?
Software
1
2003
296
0.050
 Why?
Histone Deacetylase Inhibitors
1
2020
56
0.050
 Why?
Kidney
1
2005
820
0.050
 Why?
B-Lymphocytes
1
2021
176
0.050
 Why?
Drug Resistance, Bacterial
1
2020
81
0.040
 Why?
Thrombocytopenia
1
2020
99
0.040
 Why?
Proctoscopy
1
2019
3
0.040
 Why?
Remission Induction
2
2012
221
0.040
 Why?
Cohort Studies
2
2018
1543
0.040
 Why?
Microbial Sensitivity Tests
1
2020
290
0.040
 Why?
Kaplan-Meier Estimate
1
2020
514
0.040
 Why?
Coinfection
1
2018
34
0.040
 Why?
Receptors, Chemokine
1
2017
13
0.040
 Why?
Masks
1
2018
31
0.040
 Why?
Models, Animal
1
2019
255
0.040
 Why?
Cell Survival
1
2020
657
0.040
 Why?
Statistics, Nonparametric
2
2013
232
0.040
 Why?
Neurodegenerative Diseases
1
2019
83
0.040
 Why?
Neurogenesis
1
2017
30
0.040
 Why?
Bone Marrow
1
2019
411
0.040
 Why?
Cytological Techniques
1
2017
15
0.040
 Why?
Cell Separation
1
2017
107
0.040
 Why?
Pandemics
1
2022
579
0.040
 Why?
Angiopoietin-2
1
2017
16
0.040
 Why?
Angiopoietin-1
1
2017
18
0.040
 Why?
Interleukin-2
1
2017
75
0.040
 Why?
Receptor, TIE-2
1
2017
18
0.040
 Why?
Axilla
1
2017
101
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
51
0.040
 Why?
Fluorouracil
1
2016
61
0.040
 Why?
Gene Rearrangement
1
2017
76
0.040
 Why?
Staining and Labeling
1
2017
106
0.040
 Why?
Biopsy, Needle
1
2017
195
0.040
 Why?
Chemoradiotherapy
1
2016
42
0.040
 Why?
Odds Ratio
1
2018
604
0.040
 Why?
Membrane Glycoproteins
1
2017
269
0.040
 Why?
Cord Blood Stem Cell Transplantation
1
2016
5
0.040
 Why?
Interferon-gamma
1
2017
195
0.040
 Why?
Neuroprotective Agents
1
2017
125
0.040
 Why?
Directly Observed Therapy
1
2015
8
0.040
 Why?
Mastectomy
1
2017
143
0.030
 Why?
Reagent Kits, Diagnostic
1
2015
22
0.030
 Why?
Vaginal Smears
1
2015
31
0.030
 Why?
Urine
1
2015
35
0.030
 Why?
Neoadjuvant Therapy
1
2017
125
0.030
 Why?
Prisons
1
2015
35
0.030
 Why?
Neovascularization, Pathologic
1
2017
168
0.030
 Why?
Treatment Failure
1
2015
139
0.030
 Why?
Ifosfamide
1
2015
8
0.030
 Why?
Cytarabine
1
2015
39
0.030
 Why?
Infant
1
2024
3817
0.030
 Why?
Flow Cytometry
1
2017
546
0.030
 Why?
Induction Chemotherapy
1
2014
59
0.030
 Why?
Interleukin-6
1
2016
315
0.030
 Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
21
0.030
 Why?
Matrix Metalloproteinase 2
2
2006
64
0.030
 Why?
Proto-Oncogene Proteins c-kit
1
2013
35
0.030
 Why?
Depression
1
2019
595
0.030
 Why?
Melphalan
1
2014
180
0.030
 Why?
Statistics as Topic
1
2013
103
0.030
 Why?
Cancer Care Facilities
1
2013
21
0.030
 Why?
Time
1
2013
36
0.030
 Why?
Administration, Cutaneous
1
2013
63
0.030
 Why?
Infusions, Intravenous
1
2013
231
0.030
 Why?
Specialization
1
2013
46
0.030
 Why?
Molecular Targeted Therapy
1
2013
128
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
62
0.030
 Why?
Demography
1
2013
99
0.030
 Why?
Antitrichomonal Agents
1
2012
2
0.030
 Why?
Gene Expression Regulation
1
2017
1062
0.030
 Why?
Combined Modality Therapy
1
2014
692
0.030
 Why?
Reference Values
1
2013
354
0.030
 Why?
Polyethylene Glycols
1
2012
106
0.030
 Why?
Antigens, Viral
1
2012
58
0.030
 Why?
Risk Assessment
1
2017
1361
0.030
 Why?
Medical Oncology
1
2013
102
0.030
 Why?
Administration, Topical
1
2011
71
0.020
 Why?
Single-Blind Method
1
2011
120
0.020
 Why?
Organ Size
1
2011
237
0.020
 Why?
Sex Factors
1
2013
767
0.020
 Why?
Antibodies, Viral
1
2010
124
0.020
 Why?
Neoplasm Proteins
1
2013
359
0.020
 Why?
Retrospective Studies
1
2022
6432
0.020
 Why?
Survival Rate
1
2012
951
0.020
 Why?
RNA, Viral
1
2009
141
0.020
 Why?
Anti-Retroviral Agents
1
2008
18
0.020
 Why?
Psychometrics
1
2009
241
0.020
 Why?
Busulfan
1
2008
18
0.020
 Why?
Lectins
1
2007
17
0.020
 Why?
Psychiatric Status Rating Scales
1
2009
346
0.020
 Why?
Glycosylation
1
2007
112
0.020
 Why?
Cell Count
1
2007
181
0.020
 Why?
Mutation
1
2013
1501
0.020
 Why?
Isoquinolines
1
2006
25
0.020
 Why?
Neurons, Afferent
1
2006
35
0.020
 Why?
Mice
1
2017
6413
0.020
 Why?
Maximum Tolerated Dose
1
2006
37
0.020
 Why?
Ultrasonography
1
2008
480
0.020
 Why?
Injections, Subcutaneous
1
2006
58
0.020
 Why?
Hypertension, Renal
1
2005
22
0.020
 Why?
Data Interpretation, Statistical
1
2006
177
0.020
 Why?
Microscopy, Fluorescence
1
2006
198
0.020
 Why?
Rabbits
1
2006
425
0.020
 Why?
Fatigue
1
2006
129
0.020
 Why?
Cell Proliferation
1
2009
1096
0.020
 Why?
Pyridoxine
1
2004
3
0.020
 Why?
Ribonucleotides
1
2004
5
0.020
 Why?
Vitamin B 12
1
2004
28
0.020
 Why?
Erythrocytes
1
2004
98
0.020
 Why?
Adenosine
1
2004
71
0.020
 Why?
Recombinant Proteins
1
2006
569
0.020
 Why?
Homocysteine
1
2004
126
0.020
 Why?
Endothelial Growth Factors
1
2002
8
0.010
 Why?
Vascular Endothelial Growth Factors
1
2002
16
0.010
 Why?
Lymphokines
1
2002
20
0.010
 Why?
Child, Preschool
1
2005
4147
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (475) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (25) people
_
Same Department Expand Description
Search Department